Petrovic Pajic Sanja, Fakin Ana, Jarc-Vidmar Martina, Sustar Habjan Maja, Malinar Lucija, Pavlovic Kasja, Krako Jakovljevic Nina, Isakovic Andjelka, Misirlic-Dencic Sonja, Volk Marija, Maver Ales, Jezernik Gregor, Glavac Damjan, Peterlin Borut, Markovic Ivanka, Lalic Nebojsa, Hawlina Marko
Eye Hospital, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia.
Clinic for Eye Diseases, University Clinical Centre of Serbia, 11000 Belgrade, Serbia.
Genes (Basel). 2025 Jan 20;16(1):108. doi: 10.3390/genes16010108.
The study presents a detailed examination and follow-up of a Slovenian patient with an Leber Hereditary Optic Neuropathy (LHON)-like phenotype and bilateral optic neuropathy in whom genetic analysis identified a novel variant :m.15309T>C (Ile188Thr). We provide detailed analysis of the clinical examinations of a male patient with bilateral optic neuropathy from the acute stage to 8 years of follow-up. Complete ophthalmological exam, electrophysiology and optical coherence tomography (OCT) segmentation were performed. The genotype analysis was performed with a complete screening of the mitochondrial genome. Furthermore, proteomic analysis of the protein structure and function was performed to assess the pathogenicity of a novel variant of unknown significance. Mitochondrial function analysis of the patient's peripheral blood mononuclear cells (PBMCs) was performed with the objective of evaluating the mutation effect on mitochondrial function using flow cytometry and high-resolution respirometry. The patient had a profound consecutive bilateral visual loss at 19 years of age due to optic neuropathy with characteristics of LHON; however, unlike patients with typical LHON, the patient experienced a fluctuation in visual function and significant late recovery. He had a total of three visual acuity deteriorations and improvements in the left eye, with concomitant visual loss in the right eye and a final visual acuity drop reaching nadir 9 months after onset. The visual loss was characterized by centrocecal scotoma, abnormal color vision and abnormal VEP, while deterioration of PERG N95 followed with a lag of several months. The OCT examination showed retinal nerve fiber layer thinning matching disease progression. Following a two-year period of legal blindness, the patient's visual function started to improve, and over the course of 5 years, it reached 0.5 and 0.7 Snellen (0.3 and 0.15 LogMAR) visual acuity (VA). Mitochondrial sequencing identified a presumably pathogenic variant m.15309T>C in the gene at 65% heteroplasmy, belonging to haplogroup K. Mitochondrial function assessment of the patient's PBMCs showed a lower respiration rate, an increase in reactive oxygen species production and the presence of mitochondrial depolarization, compared to an age- and sex-matched healthy control's PBMCs. A novel variant in the :m.15309T>C (Ile188Thr) gene was identified in a patient with optic nerve damage and the LHON phenotype without any additional systemic features and atypical presentation of the disease with late onset of visual function recovery. The pathogenicity of the variant is supported by proteomic analysis and the mitochondrial dysfunction observed in the patient's PBMCs.
该研究对一名斯洛文尼亚患者进行了详细检查和随访,该患者具有类似Leber遗传性视神经病变(LHON)的表型和双侧视神经病变,基因分析确定了一个新的变异:m.15309T>C(Ile188Thr)。我们提供了一名双侧视神经病变男性患者从急性期到8年随访的临床检查详细分析。进行了全面的眼科检查、电生理学检查和光学相干断层扫描(OCT)分割。通过对线粒体基因组的全面筛查进行基因型分析。此外,还进行了蛋白质结构和功能的蛋白质组学分析,以评估一个意义不明的新变异的致病性。对患者外周血单个核细胞(PBMC)进行线粒体功能分析,目的是使用流式细胞术和高分辨率呼吸测定法评估突变对线粒体功能的影响。该患者19岁时因具有LHON特征的视神经病变而出现严重的连续性双侧视力丧失;然而,与典型LHON患者不同的是,该患者视力功能出现波动且有显著的晚期恢复。他的左眼共有三次视力下降和改善,同时右眼出现视力丧失,发病9个月后最终视力下降至最低点。视力丧失的特征为中心暗点、色觉异常和VEP异常,而PERG N95的恶化则滞后数月出现。OCT检查显示视网膜神经纤维层变薄与疾病进展相符。在经历了两年的法定失明期后,患者的视力功能开始改善,在5年的时间里,视力达到了Snellen视力表0.5和0.7(LogMAR 0.3和0.15)。线粒体测序在该基因中鉴定出一个可能致病的变异m.15309T>C,异质性为65%,属于单倍群K。与年龄和性别匹配的健康对照者的PBMC相比,对患者PBMC的线粒体功能评估显示呼吸率较低、活性氧产生增加以及线粒体去极化。在一名患有视神经损伤和LHON表型且无任何其他全身特征且疾病表现不典型、视力功能恢复较晚的患者中鉴定出了:m.15309T>C(Ile188Thr)基因中的一个新变异。蛋白质组学分析以及在患者PBMC中观察到的线粒体功能障碍支持了该变异的致病性。